Bill Text: TN HB1216 | 2017-2018 | 110th General Assembly | Draft


Bill Title: As introduced, requires the commissioner of health, in consultation with the commissioner of mental health and substance abuse services, to study and report to the health committee of the house of representatives and the health and welfare committee of the senate, on or before January 15, 2018, concerning any recommended changes to prescribing guidelines for buprenorphine products, or to Tennessee Code Annotated, Section 53-11-311. - Amends TCA Title 53, Chapter 11, Part 3.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2017-02-15 - Assigned to s/c Health Subcommittee [HB1216 Detail]

Download: Tennessee-2017-HB1216-Draft.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.
feedback